| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
INAB sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 154.5K | - | - | |
| COO | 60.0K | - | - | |
| CFO | 56.3K | - | - | |
| VP | 54.0K | - | - | |
| Dir | 49.5K | $68.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Greenwood Luba | Director | Buy | 526 | $1.90 | $999.40 | +7.2% | -19.6% | -37.0% | |
| Aug 16, 2022 | Fletcher Aaron G.L.46 | Director, 10% Owner | Buy | 1,773,684 | $1.90 | $3,369,999.60 | -143.8% | -19.6% | -37.0% | |
| Aug 3, 2021 | Fairbairn Emily | Director, 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +3.1% | -22.2% | -75.4% |